中文名稱：兔抗STMN1 (Phospho-Ser16)多克隆抗體

英文名稱： Anti-STMN1 (Phospho-Ser16) rabbit polyclonal antibody

別名： Lag; SMN; OP18; PP17; PP19; PR22; LAP18; C1orf215

相關(guān)類別：一抗

儲(chǔ) 存： 冷凍（-20℃）避光

宿主： Rabbit

抗原： STMN1 (Phospho-Ser16)

反應(yīng)種屬： Human, Mouse, Rat

標(biāo) 記物： Unconjugate

克隆類型： rabbit polyclonal

技術(shù)規(guī)格

Background:

Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear

Applications:

WB, IHC

Name of antibody:

STMN1 (Phospho-Ser16)

Immunogen:

Synthetic peptide of human STMN1 (Phospho-Ser16)

Full name:

stathmin 1 (Phospho-Ser16)

Synonyms：

Lag; SMN; OP18; PP17; PP19; PR22; LAP18; C1orf215

SwissProt:

P16949

IHC positive control:

Human breast carcinoma

IHC Recommend dilution:

50-100

WB Predicted band size:

17 kDa

WB Positive control:

293 cells treated with Nocodazol

WB Recommended dilution:

500-1000

展開(kāi)全部

兔抗STMN1 (Phospho-Ser16)多克隆抗體說(shuō)明書
下載

久久综合九九-久久综合九九亚洲一区-久久综合九色-久久综合九色欧美综合狠狠-久久综合九色婷婷97-久久综合九色综合8888

021-54845833/15800441009

ELISA試劑盒

PCR試劑盒

生化試劑盒

細(xì)胞系

細(xì)胞庫(kù)

基礎(chǔ)培養(yǎng)基

完全培養(yǎng)基

原代細(xì)胞

細(xì)胞專用培養(yǎng)基

菌株

生化試劑

病理染色液

科研抗體

標(biāo)準(zhǔn)品

血清

形態(tài)病理檢測(cè)

分子病理

超微病理

產(chǎn)品中心

最新產(chǎn)品

相關(guān)文章

兔抗STMN1 (Phospho-Ser16)多克隆抗體

Background:	Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear
Applications:	WB, IHC
Name of antibody:	STMN1 (Phospho-Ser16)
Immunogen:	Synthetic peptide of human STMN1 (Phospho-Ser16)
Full name:	stathmin 1 (Phospho-Ser16)
Synonyms：	Lag; SMN; OP18; PP17; PP19; PR22; LAP18; C1orf215
SwissProt:	P16949
IHC positive control:	Human breast carcinoma
IHC Recommend dilution:	50-100
WB Predicted band size:	17 kDa
WB Positive control:	293 cells treated with Nocodazol
WB Recommended dilution:	500-1000